Brown, L. C., Halabi, S., Somarelli, J. A., Humeniuk, M., Wu, Y., Oyekunle, T., . . . Armstrong, A. J. (2022). A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer. Prostate cancer and prostatic diseases, 25(4), 762-769. https://doi.org/10.1038/s41391-022-00524-7
Citácia podle Chicago (17th ed.)Brown, Landon C., et al. "A Phase 2 Trial of Avelumab in Men with Aggressive-variant or Neuroendocrine Prostate Cancer." Prostate Cancer and Prostatic Diseases 25, no. 4 (2022): 762-769. https://doi.org/10.1038/s41391-022-00524-7.
Citácia podľa MLA (8th ed.)Brown, Landon C., et al. "A Phase 2 Trial of Avelumab in Men with Aggressive-variant or Neuroendocrine Prostate Cancer." Prostate Cancer and Prostatic Diseases, vol. 25, no. 4, 2022, pp. 762-769, https://doi.org/10.1038/s41391-022-00524-7.